Does MOSUNETUZUMAB Cause Disease progression? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Disease progression have been filed in association with MOSUNETUZUMAB (Lunsumio Velo). This represents 12.9% of all adverse event reports for MOSUNETUZUMAB.
65
Reports of Disease progression with MOSUNETUZUMAB
12.9%
of all MOSUNETUZUMAB reports
17
Deaths
4
Hospitalizations
How Dangerous Is Disease progression From MOSUNETUZUMAB?
Of the 65 reports, 17 (26.2%) resulted in death, 4 (6.2%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOSUNETUZUMAB. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does MOSUNETUZUMAB Cause?
Cytokine release syndrome (96)
Covid-19 (50)
Neutropenia (39)
Death (38)
Covid-19 pneumonia (37)
Malignant neoplasm progression (37)
Disorientation (31)
Neurological symptom (31)
Vasogenic cerebral oedema (31)
Pneumonia (30)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which MOSUNETUZUMAB Alternatives Have Lower Disease progression Risk?
MOSUNETUZUMAB vs MOSUNETUZUMAB-AXGB
MOSUNETUZUMAB vs MOXIFLOXACIN
MOSUNETUZUMAB vs MOXIFLOXACIN\MOXIFLOXACIN
MOSUNETUZUMAB vs MOXONIDINE
MOSUNETUZUMAB vs MS CONTIN